Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOY-305-01 camostat mesilate vs placebo in mild to moderate COVID-19
jRCT2031200198Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing FOY-305 (camostat mesilate) with Placebo (2 arms). Primary endpoint: Time to SARS-CoV-2 negative test. Started Nov 2020; status: completed.
02
Drugs
camostat mesilate
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCT2031200198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031200198.